1443538-50-8 Usage
General Description
(R)-2-(3,5-difluorophenyl)pyrrolidine hydrochloride is a chemical compound that belongs to the class of pyrrolidine derivatives. It is a psychoactive substance with potential therapeutic applications, as it has been studied for its ability to modulate neurotransmitter systems in the brain. The compound is known for its potential in the treatment of mental health disorders such as depression and anxiety. It is believed to act as a selective serotonin reuptake inhibitor (SSRI), working to increase the levels of serotonin in the brain. The hydrochloride salt form of this compound enhances its stability and solubility, making it more suitable for pharmaceutical applications. Its potential as a drug candidate has made it a subject of interest in the field of medicinal chemistry and drug development.
Check Digit Verification of cas no
The CAS Registry Mumber 1443538-50-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,4,3,5,3 and 8 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1443538-50:
(9*1)+(8*4)+(7*4)+(6*3)+(5*5)+(4*3)+(3*8)+(2*5)+(1*0)=158
158 % 10 = 8
So 1443538-50-8 is a valid CAS Registry Number.
1443538-50-8Relevant articles and documents
SUBSTITUTED HETEROCYCLIC COMPOUNDS AS TROPOMYOSIN RECEPTOR KINASE A (TRKA) INHIBITORS
-
Paragraph 0527 - 0529; 1681; 1682, (2015/02/05)
The present application relates to a series of substituted pyrazolo[1,5-a]pyridine compounds, their use as tropomyosin receptor kinase (Trk) family protein kinase inhibitors, method of making and pharmaceutical compositions comprising such compounds.
SUBSTITUTED PYRAZOLO[1,5-A] PYRIDINE AS TROPOMYOSIN RECEPTOR KINASE (TRK) INHIBITORS
-
Page/Page column 59; 70, (2013/07/05)
The present application relates to a series of substituted pyrazolo[1,5-a]pyridine compounds, their use as tropomyosin receptor kinase (Trk) family protein kinase inhibitors., method of making and pharmaceutical compositions comprising such compounds.
